Connect Biopharma Holdings Free Cash Flow (FCF) History (CNTB)

Connect Biopharma Holdings reported −$51.6M in free cash flow for fiscal 2025, a decrease of $27.3M from the previous fiscal year, with a free cash flow margin of −80687.50%.

View full Connect Biopharma Holdings company overview

Connect Biopharma Holdings free cash flow by year

Connect Biopharma Holdings annual free cash flow

Fiscal yearPeriod endedFree cash flowChangeGrowthFCF margin
20252025-12-31−$51.6M−$27.3M−80687.50%
20242024-12-31−$24.4M$23.5M−93.58%
20232023-12-31−$47.8M$58.1M
20222022-12-31−$105.9M−$17.8M
20212021-12-31−$88.2M

Connect Biopharma Holdings free cash flow growth trends

Connect Biopharma Holdings's latest reported quarter, Q2 2026, generated −$15.9M in free cash flow, a decrease of $3.0M year over year.

About the metric

What free cash flow means

Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.

Calculation and source

How free cash flow is calculated

TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.

Review Connect Biopharma Holdings filings at SEC.gov ↗